Athletigen Technologies Is Diving Into The Genetics Of Athletes To Make Them Perform Better


With the help of Exponential Partners, Athletigen Technologies, Inc., a sports genetics company, has raised $1.55 million in seed funding for its Athletigen Performance Platform.

Athletigen analyzes athletes’ genetic profiles and presents the information through their interface to allow athletes to better understand their bodies.  Through looking at 850,000 genetic variants, Athletigen can tell athletes volumes about their bodies and how this affects physical performance.

The funding raised will go towards furthering this human performance program.  The consumer market for genetical analysis is growing, and Athletigen is looking to take advantage.

Get The Latest Sports Tech News In Your Inbox!

The CEO of Athletigen, Jeremy Koenig, Ph.D., said, “We are proud of what our outstanding team has accomplished to date, launching the world’s most comprehensive sports genetic analysis platform.  We welcome the confidence and guidance of Exponential Partners and our other investors and look forward to using these new resources to establish Athletigen as the leading human performance brand in the field of genomics.”

Exponential Partners, which funded this project, is a venture capital fund that specializes in opportunities related to human health and performance. One of their general partners, Pat Wilkison, will join the Board of Directors at Athletigen to help see it through.

Wilkison said, “Athletigen is leading the charge of a genomic revolution, making this an exciting investment opportunity.  Their unique ability to analyze individual athletic traits and recommend effective actions holds tremendous potential, particularly as advances in technology have made genetic testing so affordable.  With a staff consisting of high performance athletes and the top scientific minds in applied genomics, their knowledge of both athletics and science makes them unrivaled in the industry.  We are infinitely committed to providing the support needed to help fuel the adoption of Athletigen by the world’s athletes.”

This is an emerging industry, and it will be interesting to see where Athletigen can take it.  It looks like we might not be that far from a world where athletes know exactly the fine-tunings of their bodies and just how far they can go.